Platelet effects of arachidonic acid in dog blood. I. Lack of involvement of cyclo-oxygenase in the in vivo situation.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000721:Ancrod / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D007213:Indomethacin / Q000494:pharmacology; D008041:Linoleic Acids / Q000494:pharmacology; D008297:Male; D010105:Oxygenases / Q000097:blood*; D010974:Platelet Aggregation / Q000187:drug effects*; D011458:Prostaglandins E / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D013921:Thrombocytopenia / Q000139:chemically induced
D001095:Arachidonic Acids; D008041:Linoleic Acids; D011458:Prostaglandins E; D011748:Pyrogallol; D000244:Adenosine Diphosphate; D010105:Oxygenases; D000721:Ancrod; D013917:Thrombin; D001241:Aspirin; D007213:Indomethacin